» Articles » PMID: 26290044

Comparative Effectiveness and Tolerance of Treatments for Helicobacter Pylori: Systematic Review and Network Meta-analysis

Overview
Journal BMJ
Specialty General Medicine
Date 2015 Aug 21
PMID 26290044
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the most efficacious treatment for eradication of Helicobacter pylori with the lowest likelihood of some common adverse events among pre-recommended and newer treatment regimens.

Design: Systematic review and network meta-analysis.

Data Sources: Cochrane Library, PubMed, and Embase without language or date restrictions.

Study Selection: Full text reports of randomised controlled trials that compared different eradication treatments for H pylori among adults.

Results: Of the 15,565 studies identified, 143 were eligible and included. Data on 14 kinds of treatments were available. Of 91 possible comparisons for the efficacy outcome, 34 were compared directly and the following treatments performed better: seven days of concomitant treatment (proton pump inhibitor and three kinds of antibiotics administered together), 10 or 14 days of concomitant treatment, 10 or 14 days of probiotic supplemented triple treatment (standard triple treatment which is probiotic supplemented), 10 or 14 days of levofloxacin based triple treatment (proton pump inhibitor, levofloxacin, and antibiotic administered together), 14 days of hybrid treatment (proton pump inhibitor and amoxicillin used for seven days, followed by a proton pump inhibitor, amoxicillin, clarithromycin, and 5-nitroimidazole for another seven days), and 10 or 14 days of sequential treatment (five or seven days of a proton pump inhibitor plus amoxicillin, followed by five or seven additional days of a proton pump inhibitor plus clarithromycin and 5-nitroimidazole or amoxicillin). In terms of tolerance, all treatments were considered tolerable, but seven days of probiotic supplemented triple treatment and seven days of levofloxacin based triple treatment ranked best in terms of the proportion of adverse events reported.

Conclusion: Comparison of different eradication treatments for H pylori showed that concomitant treatments, 10 or 14 days of probiotic supplemented triple treatment, 10 or 14 days of levofloxacin based triple treatment, 14 days of hybrid treatment, and 10 or 14 days of sequential treatment might be better alternatives for the eradication of H pylori.

Citing Articles

First-Line Levofloxacin-Based Triple Therapy Versus Standard Bismuth-Based Quadruple Therapy for Eradication in Saudi Arabia: A Retrospective Single-Center Study.

Abdulqader A, Alamri T, Alhamad M, Shehab El-Deen S, Essa A, Alfayez R Health Sci Rep. 2025; 8(2):e70432.

PMID: 39917596 PMC: 11798733. DOI: 10.1002/hsr2.70432.


Oral Hygiene With Neutral Electrolyzed Water and Systemic Therapy Increases Gastric Helicobacter pylori Eradication and Reduces Recurrence.

Urrutia-Baca V, Paz-Michel B, Calderon-Porras A, Valle J, Alvarez-Fernandez W, Mervitch-Sigal N Clin Exp Dent Res. 2024; 10(4):e927.

PMID: 38973212 PMC: 11228356. DOI: 10.1002/cre2.927.


Real-world evidence of a novel tetravalent immunoglobulin Y effectiveness and safety in patients with the refractory Helicobacter pylori infection.

Hao N, Liu B, Zhao M, Lu M, Chen F, Kang J BMC Infect Dis. 2024; 24(1):647.

PMID: 38937679 PMC: 11210110. DOI: 10.1186/s12879-024-09498-4.


The effects of probiotics supplementation on Helicobacter pylori standard treatment: an umbrella review of systematic reviews with meta-analyses.

Yang Z, Zhou Y, Han Z, He K, Zhang Y, Wu D Sci Rep. 2024; 14(1):10069.

PMID: 38697990 PMC: 11066092. DOI: 10.1038/s41598-024-59399-4.


Efficacy and safety of seven Chinese patent medicines combined with conventional triple/quadruple therapy for -positive peptic ulcers: a systematic review and network meta-analysis.

Jiang Z, Deng B, Zhang Y, Li Y, Yu Z, Deng H BMJ Open. 2024; 14(4):e074188.

PMID: 38684278 PMC: 11086278. DOI: 10.1136/bmjopen-2023-074188.


References
1.
Du Y, Su T, Fan J, Lu Y, Zheng P, Li X . Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection. World J Gastroenterol. 2012; 18(43):6302-7. PMC: 3501780. DOI: 10.3748/wjg.v18.i43.6302. View

2.
Yuan J, Zhang R, Yang Z, Lee J, Liu Y, Tian J . Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013; 63(5):902-12. DOI: 10.1016/j.eururo.2013.01.012. View

3.
Zou J, Dong J, Yu X . Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication. Helicobacter. 2009; 14(5):97-107. DOI: 10.1111/j.1523-5378.2009.00716.x. View

4.
McColl K . Clinical practice. Helicobacter pylori infection. N Engl J Med. 2010; 362(17):1597-604. DOI: 10.1056/NEJMcp1001110. View

5.
Malfertheiner P, Megraud F, OMorain C, Bazzoli F, El-Omar E, Graham D . Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2006; 56(6):772-81. PMC: 1954853. DOI: 10.1136/gut.2006.101634. View